February 15, 2022 Comments Off on New patent for Abbvie Inc drug RINVOQ Posted in: Patent Added Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are ten patents…
The post New patent for Abbvie Inc drug RINVOQ appeared first on DrugPatentWatch – M…
February 15, 2022 Comments Off on Drug Patent Expirations for the Week of February 13, 2022 Posted in: Uncategorized
KYNMOBI (apomorphine hydrochloride) Sunovion pharms inc Patent: 9,855,221 Expiration: Feb 14, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expir…
